Discover life science companies across the East of England, including biotechnology firms, CROs, research organisations and innovation hubs.
Blood-based circulating tumour DNA tests for cancer
Inivata is a liquid biopsy company developing molecular tests for cancer using circulating tumour DNA from blood samples. Its sequencing-based assays identify tumour-associated genetic changes and have been used to investigate residual disease, recurrence and treatment response. The technology supports molecular…
Rare and serious disease therapeutics with Cambridge R&D hub
Insmed is a US biopharmaceutical company with commercial-stage and late-pipeline products spanning respiratory, inflammatory and rare neurological diseases. Its Cambridge facility at Babraham Research Campus, established through the 2023 acquisition of Adrestia, leads drug discovery using the company's synthetic…
Europe's oldest science park, anchored by Cambridge University
Cambridge Science Park is Europe's first science park, founded by Trinity College, Cambridge in 1970 and spanning 152 acres on the northern edge of the city. Trinity College retains the freehold and continues to invest actively in the estate. The park hosts 170 science and technology companies employing over 7,000…
Antibody-oligonucleotide conjugates for spatial biology and proteomics
AbOliGo is a biotechnology company developing antibody-oligonucleotide conjugates (AOCs) for multiplexed protein analysis, spatial biology and single-cell workflows. Its conjugation platform addresses a critical bottleneck in multiomic research, as fewer than 0.1% of commercially available antibodies are currently…
Human biospecimens and rapid tests for diagnostic applications
SeraDiag is a supplier of human biospecimens and rapid diagnostic tests for laboratory research, in vitro diagnostics and personal health screening. It provides characterised human serum, plasma and residual clinical samples from healthy and disease-state donors for assay development, quality control and…
Antibody therapeutics for inflammatory and autoimmune disease
MabGalaxy develops antibody therapeutics for inflammatory and autoimmune diseases, with scientific operations linked to Cambridge's Babraham Research Campus. Its discovery approach combines immune-system biology with artificial intelligence to support antibody design and selection. The company aims to shorten the…
In vitro respiratory and inhalation toxicology testing services
ImmuONE is a contract research company specialising in in vitro inhalation toxicology and respiratory safety assessment. The company develops and applies human alveolar macrophage and epithelial cell culture models to evaluate the safety and efficacy of inhaled compounds, providing an alternative to animal testing.…
Human iPSC-derived disease models and drug discovery services
Axol Bioscience is a biotechnology company supplying human induced pluripotent stem cell-derived cells and research services for disease modelling and drug discovery. Its portfolio includes neurons, cardiomyocytes, retinal organoids, retinal pigment epithelium and skin cell models, alongside culture media and custom…
Global biopharma with UK R&D hub in Hertfordshire
Roche Products is the UK pharmaceutical arm of F. Hoffmann-La Roche, headquartered at Welwyn Garden City in Hertfordshire. The site employs over 1,900 people and serves as a primary hub for early-stage drug discovery, clinical development, computational sciences, and commercial operations. The UK operation contributes…
AI-assisted imaging software for minimally invasive vascular surgery
Cydar Medical is a medical software company developing AI-assisted imaging tools for minimally invasive vascular surgery. Its cloud-based platform creates three-dimensional anatomical maps from CT scans and overlays them on live X-ray images to support procedural planning and intraoperative navigation. The software…
Yeast-based production platform for veterinary antibody therapeutics
HERlab develops microbial production systems for animal therapeutics using synthetic biology. Its platform applies AI-driven selection across more than a thousand yeast species to match therapeutic proteins with suitable production hosts. It also develops purification technology with veterinary manufacturing costs in…
Innovation campus and incubation space for agritech and life science businesses
Rothamsted Enterprises operates the innovation campus at Rothamsted Research in Harpenden, providing flexible office and laboratory space for agritech and life science businesses. The campus offers conference and meeting facilities, tenant support services, and access to shared scientific equipment and the wider…
AI-enabled biologics discovery and therapeutic development
Divergence Labs develops new medicines by combining molecular engineering, machine learning and high-throughput biological experimentation. Its Cambridge research team integrates antibody and biologics discovery, cell engineering and automated screening to identify and optimise therapeutic candidates. Proprietary…
Complex molecule synthesis and chemistry-driven cancer drug discovery
New Path Molecular Research is a Cambridge-based chemistry company spun out from the laboratory of Professor Steve Ley at the University of Cambridge. The company specialises in the synthesis of complex functional molecules, including natural products, macrocycles and peptides, using flow chemistry and…
Combinatorial stem cell screening platform for therapy development
Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial screening to test thousands of cell culture variable combinations in parallel, identifying optimised protocols for stem cell expansion,…
AAV gene therapies for rare and neurological diseases
Spur Therapeutics is a clinical-stage biotechnology company developing adeno-associated virus-based gene therapies for serious chronic diseases. Its lead programme is a Phase I/II gene therapy for Gaucher disease type 1, a rare lysosomal storage disorder. Further pipeline candidates target GBA1 Parkinson's disease and…
Precision oncology biotech targeting synthetic lethality in cancer
Tessellate Bio is a precision oncology company developing small molecule drugs that exploit synthetic lethality, the principle that certain genetic vulnerabilities in cancer cells can be targeted to selectively kill tumour cells. The company's lead programme targets the FANCM complex in cancers relying on Alternative…
Molecular assay platform for genomic profiling in cancer diagnostics
Biofidelity is a Cambridge-based genomic technology company developing molecular assays for cancer biomarker detection in tissue and liquid biopsy samples. Its proprietary platform enables ultra-sensitive detection of somatic mutations at low variant allele fractions using a simplified four-step qPCR workflow, without…
Connecting UK bioinformatics data services, standards and training
ELIXIR-UK is the United Kingdom's national node of ELIXIR, a distributed European infrastructure supporting biological data research. Coordinated from the Earlham Institute, it connects universities and research organisations that develop and maintain bioinformatics tools, datasets, standards and training. The network…
Rapid blood biomarker test for pre-hospital stroke triage
Upfront Diagnostics is a diagnostic biotechnology company developing rapid blood tests for emergency stroke triage. Its lateral-flow assay measures D-dimer and glial fibrillary acidic protein (GFAP) from a finger-prick sample, providing results in under ten minutes to support identification of suspected…